Murthy VK - Search Results

1

Mini-exon gene variation in human pathogenic Leishmania species.

Fernandes O, Murthy VK, Kurath U, Degrave WM, Campbell DA. Fernandes O, et al. Among authors: murthy vk. Mol Biochem Parasitol. 1994 Aug;66(2):261-71. doi: 10.1016/0166-6851(94)90153-8. Mol Biochem Parasitol. 1994. PMID: 7808476

2

PCR amplification of mini-exon genes differentiates Trypanosoma cruzi from Trypanosoma rangeli.

Murthy VK, Dibbern KM, Campbell DA. Murthy VK, et al. Mol Cell Probes. 1992 Jun;6(3):237-43. doi: 10.1016/0890-8508(92)90022-p. Mol Cell Probes. 1992. PMID: 1406732

3

The mini-exon gene of Trypanosoma (Nannomonas) simiae: sequence variation between isolates and a distinguishing molecular marker.

Sturm NR, Murthy VK, Garside L, Campbell DA. Sturm NR, et al. Among authors: murthy vk. Acta Trop. 1998 Sep 15;71(2):199-206. doi: 10.1016/s0001-706x(98)00056-4. Acta Trop. 1998. PMID: 9821469

4

Impact of ⁶⁸Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.

Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. Fendler WP, et al. J Nucl Med. 2020 Dec;61(12):1793-1799. doi: 10.2967/jnumed.120.242180. Epub 2020 May 1. J Nucl Med. 2020. PMID: 32358094 Free PMC article. Clinical Trial.

5

The Emerging Role of Next-Generation Imaging in Prostate Cancer.

Murthy V, Aggarwal R, Koo PJ. Murthy V, et al. Curr Oncol Rep. 2022 Jan;24(1):33-42. doi: 10.1007/s11912-021-01156-1. Epub 2022 Jan 20. Curr Oncol Rep. 2022. PMID: 35059998 Review.

6

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.

Gafita A, Rauscher I, Fendler WP, Murthy V, Hui W, Armstrong WR, Herrmann K, Weber WA, Calais J, Eiber M, Weber M, Benz MR. Gafita A, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4271-4281. doi: 10.1007/s00259-022-05882-x. Epub 2022 Jun 29. Eur J Nucl Med Mol Imaging. 2022. PMID: 35767071

7

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with ¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.

Murthy V, Gafita A, Thin P, Nguyen K, Grogan T, Shen J, Drakaki A, Rettig M, Czernin J, Calais J. Murthy V, et al. J Nucl Med. 2023 Nov;64(11):1737-1743. doi: 10.2967/jnumed.122.265155. Epub 2023 Sep 7. J Nucl Med. 2023. PMID: 37678927 Free article.

8

PSMA-Negative Lesion Progression Under ¹⁷⁷Lu-PSMA Radioligand Therapy.

Murthy V, Allen-Auerbach M, Lam R, Owen D, Czernin J, Calais J. Murthy V, et al. J Nucl Med. 2023 Sep;64(9):1502-1503. doi: 10.2967/jnumed.122.265099. Epub 2023 Jun 15. J Nucl Med. 2023. PMID: 37321828 Free article. No abstract available.

9

⁶⁸Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality.

Murthy V, Smith RL, Tao DH, Lawhn-Heath CA, Korenchan DE, Larson PEZ, Flavell RR, Hope TA. Murthy V, et al. EJNMMI Phys. 2020 Aug 26;7(1):54. doi: 10.1186/s40658-020-00322-x. EJNMMI Phys. 2020. PMID: 32844310 Free PMC article.

10

The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer.

Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS, Hope TA. Murthy V, et al. Eur Urol Focus. 2021 Mar;7(2):258-266. doi: 10.1016/j.euf.2021.01.016. Epub 2021 Feb 2. Eur Urol Focus. 2021. PMID: 33541838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters